- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 124,060 | 18.07.24 21:46:27 | -1,830 | -1,45% | 124,060 | 124,080 | 125,300 | 125,890 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 99,070 | 18.07.24 21:46:04 | -2,000 | -1,98% | 98,900 | 99,280 | 100,500 | 101,070 |
